文献速递胸部CT

双能量能谱CT定量特征用于识别肺腺癌表皮生长因子受体突变

Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
PubMed 文献 · Eur Radiol · 2018-10-26

回顾性纳入120例肺腺癌患者,评估双能量能谱CT定量参数与EGFR突变状态的关系。EGFR突变组66例(55.0%),多因素分析显示吸烟史(OR=3.23,p=0.005)和归一化碘浓度(OR=58.026,p=0.049)为显著预测因素,联合预测AUC为0.702。作者认为归一化碘浓度可能是预测EGFR突变的潜在定量参数。

要点

  • 归一化碘浓度(NIC)与EGFR突变状态相关,多因素OR=58.026(p=0.049)。
  • 吸烟史与EGFR突变状态相关,多因素OR=3.23(p=0.005)。
  • 吸烟史联合NIC预测EGFR突变的AUC为0.702。

核心结论

  • 归一化碘浓度可能是预测肺腺癌患者EGFR突变的潜在双能量能谱CT定量参数。

研究设计与样本

  • 回顾性研究,从本机构数据库选取同时接受双能量能谱CT胸部检查和EGFR检测的肺腺癌患者120例,比较EGFR突变组与野生型组。

诊断标准与关键数值

  • 单因素分析显示性别、吸烟史、CT纹理、NIC和光谱衰减曲线斜率λ HU与EGFR突变状态显著相关(p分别为0.037、0.001、0.047、0.010、0.018)。
  • 多因素logistic分析显示吸烟史(OR=3.23,p=0.005)和NIC(OR=58.026,p=0.049)为与EGFR突变相关的显著预测因素。
  • 吸烟史联合NIC预测EGFR突变的曲线下面积为0.702。

临床应用与阅片要点

  • 作者认为NIC可能是预测肺腺癌EGFR突变的潜在定量双能量能谱CT参数。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the role of dual-energy spectral computed tomography (DESCT) quantitative characteristics for the identification of epidermal growth factor receptor (EGFR) mutation status in a cohort of East Asian patients with pulmonary adenocarcinoma.

MATERIALS AND METHODS: Patients with lung adenocarcinoma who underwent both DESCT chest examination and EGFR test were retrospectively selected from our institution's database. The DESCT visual morphological features and quantitative parameters, including the CT number at 70 keV, normalized iodine concentration (NIC), normalized water concentration, and slopes of the spectral attenuation curves (slope λ HU [Hounsfield unit]), were evaluated or calculated. The patients were divided into two groups: the EGFR mutation group and EGFR wild-type group. Statistical analyses were performed to identify the DESCT quantitative parameters for diagnosis of EGFR mutation status.

RESULTS: EGFR mutations were detected in 66 (55.0%) of the 120 enrolled patients. The univariate analysis revealed that sex, smoking history, CT texture, NIC, and slope λ HU were significantly associated with EGFR mutation status (p = 0.037, 0.001, 0.047, 0.010, and 0.018, respectively). The multivariate logistic analysis revealed that smoking history (odds ratio [OR] = 3.23, p = 0.005) and NIC (OR = 58.026, p = 0.049) were the two significant predictive factors associated with EGFR mutations. Based on this analysis, the smoking history and NIC were combined to determine the predictive value for EGFR mutations with the area under the curve of 0.702.

CONCLUSIONS: NIC may be a potential quantitative DESCT parameter for predicting EGFR mutations in patients with pulmonary adenocarcinoma.

KEY POINTS: • DESCT can provide multiple quantitative image parameters compared to conventional CT. • Identification of the radio-genomic relation between DESCT and EGFR status can help to define molecular subcategories of lung adenocarcinoma, which is valuable for personalized clinical targeted therapy. • NIC may be a potential DESCT quantitative parameter for predicting EGFR mutations in pulmonary adenocarcinoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li M, Zhang L, Tang W, et al. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography. Eur Radiol. 2018. PMID: 30367185. doi:10.1007/s00330-018-5756-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。